Back to Directory
Last Updated: 08/06/2026
Vitarka Therapeutics
South East England
Founded 2021
Non-viral intracellular drug delivery for solid tumours
Vitarka Therapeutics is a preclinical biotech company developing a non-viral drug delivery platform for targeted intracellular delivery of therapeutics to solid tumours.
The technology uses pore-forming proteins to transport RNAi therapies and other payloads directly into cancer cells while limiting off-target toxicity.
The company has raised over £1.27m from SOSV, the UK Innovation and Science Seed Fund, and Innovate UK, and completed the IndieBio New York accelerator programme.